-transparent.png){kind=logo}
A hospitalized 22-year-old woman had suffered from Wilson's disease for the past 11 years. The diagnosis was confirmed by hepatic nonspecific changes, high copper urine excretion, and low to zero serum ceruloplasmin, but psychiatric symptomatology was the main manifestation of the disease. The history of treatment modalities and a controlled trial with penicillamine revealed a clear priority of this drug over phenothiazines in abolishing the psychotic features of the disease. The effective dose in this case was found to be over 1650 mg/day. The mental state, as measured by the Brief Psychiatric Rating Scale, was clearly correlated to the dose of penicillamine. In addition, there was a tendency to increased copper excretion with penicillamine treatment. This case suggests a connection between copper brain poisoning and the related acute psychotic features, which responded well to penicillamine treatment.
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
April 1980,
Southern medical journal,
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
October 1956,
The American journal of medicine,
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
June 1960,
Canadian Medical Association journal,
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
July 1982,
Lancet (London, England),
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
June 1982,
Lancet (London, England),
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
August 1982,
Lancet (London, England),
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
September 1979,
Psychiatrie, Neurologie, und medizinische Psychologie,
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
December 1970,
The American journal of the medical sciences,
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
May 1968,
Lancet (London, England),
I Modai, and
L Karp, and
U A Liberman, and
H Munitz
May 1990,
Archives of neurology,
